Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc. has met with MPs 16 times since January 2024, reaching 11 MPs across 2 parties. Most recent contact: December 4, 2025.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.
December 4, 2025 · Marjorie Michel · Liberal · Health; Industry
Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda.
November 6, 2025 · Jennifer McKelvie · Liberal · Health; Industry
Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.
October 27, 2025 · Marc Miller · Liberal · Health; Industry
Full meeting log
16 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2025-12-04 | Marjorie Michel · Liberal |
| 2025-11-27 | Marjorie Michel · Liberal |
| 2025-11-25 | Michael Coteau · Liberal |
| 2025-11-25 | Tom Kmiec · Conservative |
| 2025-11-14 | Karim Bardeesy · Liberal |
| 2025-11-06 | Jennifer McKelvie · Liberal |
| 2025-11-03 | Evan Solomon · Liberal |
| 2025-10-27 | Marc Miller · Liberal |
| 2025-10-27 | Jeremy Patzer · Conservative |
| 2025-10-09 | Karim Bardeesy · Liberal |
| 2025-10-09 | Mike Lake · Conservative |
| 2024-09-23 | Peter Fragiskatos · Liberal |
| 2024-09-23 | Matt Jeneroux · Liberal |
| 2024-05-14 | Tom Kmiec · Conservative |
| 2024-05-07 | Tom Kmiec · Conservative |
| 2024-02-29 | Tom Kmiec · Conservative |